Arbutus Biopharma
PA - WarminsterPharmaceutical
Focus: Arbutus Biopharma is a specialized RNAi-focused biotech company headquartered in Warminster, PA, developing gene therapy and RNAi-based therapeutics primarily for hepatitis B and other rare diseases. The company operates at mid-stage clinical development with no marketed products and limited disclosed scale metrics.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Arbutus Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Arbutus Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TKM-100802 for Injection
Ebola Virus InfectionClinical Trials (1)
NCT02041715Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Phase 1Help build intelligence for Arbutus Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.